Device Trial Radar · NCT07473817
Validation of Different Methods for HepQuant DuO® Blood Sample Collection
Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Sep 18, 2026
Primary completion
Feb 18, 2027
Study completion Sep 18, 2027
Sponsor
- Lead sponsor
- HepQuant, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 16, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a study to see the agreement of blood samples collected through different means and tube types for the HepQuant DuO Test. The HepQuant DuO Test is a blood-based test that involves a drink of a natural compound, cholate, and blood samples at 20 and 60 minutes. The study team is collecting clinical and laboratory data from patients living with chronic liver disease and healthy adult volunteers. The study has up to 2 study visits at an outpatient clinic and can take up to 4 weeks for a participant to complete study. At these visits, participants will undergo a HepQuant DuO test and other standard lab tests. In addition, the study team will ask about a participant's experience with different blood sampling methods.
Conditions
- Healthy Adult Participants
- Liver Disease Chronic
Interventions
HepQuant DuO TestDevice
HepQuant DuO is commercially available in the U.S. as a Laboratory Developed Test (LDT), but it will be used in this study as a nonsignificant risk investigational device to measure change in liver function over time.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference in d4-cholate concentrations between RTs by VP (reference method) and the SSTs by VP (primary index method).Time frame: From screening to completion of blood collection at Visit 1 is 2 weeks.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.